North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 0.985

-5.3%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (192)	1/3/1998 7:54:00 AM
From: Don W Stone	Read Replies (1) of 507

Well; If anyone is concerned about APPROVAL, just start thinking IMMINENT. Yes, it has been a long, perhaps unexplainable time, but the picture for NVX just keeps getting better. To start with not more than a year ago it was though that the market for DTaP would be divided 5 ways. Not so anymore. It appears there will only be 3 suppliers in the U.S. . Lederle, Connaught, and NVX. The big question that remains to be answered is : Just how will the market react to the fact that all of NVX's competitors have experienced serious adverse events with their vaccines and NVX has experienced none. In addition NVX's CERTIVA has demonstrarted in trials that it is more effective than the 2 vaccines now being marketed here. I would like to think we have every reason to be very optimistic. I do know what vaccine my future grandchildren will be getting, that is for sure. I should also mention that NVX will be following up Certiva with a DTaP-IPV vaccine in a relatively near period of time. This latter vaccine is already being marketed in Europe. I would expect to see alot of very good news coming out of NVX following approval. IT WILL BE WORTH THE WAIT IN '98. :-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next